Key result
Intravenous immunoglobulins resulted in an excellent outcome with no cutaneous or neurologic sequelae in a 10-year-old boy with enterovirus 71 meningoencephalitis during chemotherapy.
Case Report (n=1)
Intravenous immunoglobulins may be considered for severe invasive enteroviral infections in pediatric oncology patients.
May support IVIG consideration in similar cases; hypothesis-generating pending prospective trials.
Enterovirus meningoencephalitis is rare but can be severe. Very few cases of these infections have been reported in pediatric oncology. We report the case of a 10-year-old boy with tibial osteosarcoma and lung metastases who developed enterovirus 71 meningoencephalitis during aplasia. Clinical features comprised fever, hypotension, vesicular rash, generalized seizures, and altered consciousness. Diagnosis was confirmed by polymerase chain reaction on samples of cerebrospinal fluid and skin vesicles. The patient received treatment with intravenous immunoglobulins with an excellent outcome with no cutaneous or neurologic sequelae. Immunoglobulin therapy could be considered in cases of invasive enteroviral infection with such severity in pediatric oncology.
No takes yet. Share an insight, caveat, or question.
Frange et al. (2007) conducted a case report in Enterovirus 71 meningoencephalitis during chemotherapy for metastatic osteosarcoma (n=1). Intravenous immunoglobulins was evaluated on Clinical outcome. Intravenous immunoglobulins resulted in an excellent outcome with no cutaneous or neurologic sequelae in a 10-year-old boy with enterovirus 71 meningoencephalitis during chemotherapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: